Global Endocrine Testing Industry

Global Endocrine Testing Market to Reach $13. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Endocrine Testing estimated at US$8. 6 Billion in the year 2020, is projected to reach a revised size of US$13.

New York, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Endocrine Testing Industry" - https://www.reportlinker.com/p05956690/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Estradiol (E2) Testing, one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Follicle Stimulating Hormone (FSH) Testing segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 9.9% CAGR

The Endocrine Testing market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 9.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Human Chorionic Gonadotropin (hCG) Hormone Testing Segment to Record 5.1% CAGR

In the global Human Chorionic Gonadotropin (hCG) Hormone Testing segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$320.7 Million in the year 2020 will reach a projected size of US$442.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period. We bring years of research experience to this 5th edition of our report. The 415-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• AB SCIEX LLC

• Abbott Laboratories, Inc.

• Agilent Technologies, Inc.

• Alfa Aesar, A Thermo Fisher Scientific Company

• bioMerieux SA

• Bio-Rad Laboratories, Inc.

• DiaSorin, Inc.

• F. Hoffmann-La Roche AG

• Laboratory Corporation of America Holdings (LabCorp)

• Ortho-Clinical Diagnostics

• Quest Technology (S) Pte Ltd.

• Sysmex Corporation

• Teleflex Inc.

Read the full report: https://www.reportlinker.com/p05956690/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Endocrine Testing Competitor Market Share Scenario Worldwide:
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Endocrine Testing Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Endocrine Testing Global Retrospective Market Scenario
in US$ Million by Region/Country: 2012-2019

Table 3: Endocrine Testing Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Insulin Testing (Test Type) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 5: Insulin Testing (Test Type) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019

Table 6: Insulin Testing (Test Type) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 7: Follicle Stimulating Hormone (FSH) Testing (Test Type)
Potential Growth Markets Worldwide in US$ Million: 2020 to 2027

Table 8: Follicle Stimulating Hormone (FSH) Testing (Test Type)
Historic Market Perspective by Region/Country in US$ Million:
2012 to 2019

Table 9: Follicle Stimulating Hormone (FSH) Testing (Test Type)
Market Sales Breakdown by Region/Country in Percentage: 2012 VS
2020 VS 2027

Table 10: Human Chorionic Gonadotropin (hCG) Hormone Testing
(Test Type) Geographic Market Spread Worldwide in US$ Million:
2020 to 2027

Table 11: Human Chorionic Gonadotropin (hCG) Hormone Testing
(Test Type) Region Wise Breakdown of Global Historic Demand in
US$ Million: 2012 to 2019

Table 12: Human Chorionic Gonadotropin (hCG) Hormone Testing
(Test Type) Market Share Distribution in Percentage by
Region/Country: 2012 VS 2020 VS 2027

Table 13: Luteinizing Hormone (LH) Testing (Test Type) World
Market Estimates and Forecasts by Region/Country in US$
Million: 2020 to 2027

Table 14: Luteinizing Hormone (LH) Testing (Test Type) Market
Historic Review by Region/Country in US$ Million: 2012 to 2019

Table 15: Luteinizing Hormone (LH) Testing (Test Type) Market
Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 16: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test
Type) World Market by Region/Country in US$ Million: 2020 to
2027

Table 17: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test
Type) Historic Market Analysis by Region/Country in US$
Million: 2012 to 2019

Table 18: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test
Type) Market Share Distribution in Percentage by
Region/Country: 2012 VS 2020 VS 2027

Table 19: Progesterone Testing (Test Type) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2020
to 2027

Table 20: Progesterone Testing (Test Type) Market Worldwide
Historic Review by Region/Country in US$ Million: 2012 to 2019

Table 21: Progesterone Testing (Test Type) Market Percentage
Share Distribution by Region/Country: 2012 VS 2020 VS 2027

Table 22: Testosterone Testing (Test Type) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027

Table 23: Testosterone Testing (Test Type) Global Historic
Demand in US$ Million by Region/Country: 2012 to 2019

Table 24: Testosterone Testing (Test Type) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 25: Thyroid Stimulating Hormone (TSH) Testing (Test Type)
World Market by Region/Country in US$ Million: 2020 to 2027

Table 26: Thyroid Stimulating Hormone (TSH) Testing (Test Type)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019

Table 27: Thyroid Stimulating Hormone (TSH) Testing (Test Type)
Market Share Breakdown of Worldwide Sales by Region/Country:
2012 VS 2020 VS 2027

Table 28: Prolactin Testing (Test Type) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027

Table 29: Prolactin Testing (Test Type) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019

Table 30: Prolactin Testing (Test Type) Market Sales Breakdown
by Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 31: Cortisol Testing (Test Type) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027

Table 32: Cortisol Testing (Test Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2012 to 2019

Table 33: Cortisol Testing (Test Type) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 34: Estradiol (E2) Testing (Test Type) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 35: Estradiol (E2) Testing (Test Type) Historic Market
Analysis by Region/Country in US$ Million: 2012 to 2019

Table 36: Estradiol (E2) Testing (Test Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027

Table 37: Other Test Types (Test Type) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 38: Other Test Types (Test Type) Historic Market Analysis
by Region/Country in US$ Million: 2012 to 2019

Table 39: Other Test Types (Test Type) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 40: Adrenal Disorders (Endocrine Disorders) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2020
to 2027

Table 41: Adrenal Disorders (Endocrine Disorders) Market
Worldwide Historic Review by Region/Country in US$ Million:
2012 to 2019

Table 42: Adrenal Disorders (Endocrine Disorders) Market
Percentage Share Distribution by Region/Country: 2012 VS 2020
VS 2027

Table 43: Calcium Problems (Endocrine Disorders) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2020 to 2027

Table 44: Calcium Problems (Endocrine Disorders) Global
Historic Demand in US$ Million by Region/Country: 2012 to 2019

Table 45: Calcium Problems (Endocrine Disorders) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 46: Glucose (islet cells) Disorders (Endocrine Disorders)
World Market by Region/Country in US$ Million: 2020 to 2027

Table 47: Glucose (islet cells) Disorders (Endocrine Disorders)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019

Table 48: Glucose (islet cells) Disorders (Endocrine Disorders)
Market Share Breakdown of Worldwide Sales by Region/Country:
2012 VS 2020 VS 2027

Table 49: Male and Female Gonadal Problems (Endocrine
Disorders) Potential Growth Markets Worldwide in US$ Million:
2020 to 2027

Table 50: Male and Female Gonadal Problems (Endocrine
Disorders) Historic Market Perspective by Region/Country in US$
Million: 2012 to 2019

Table 51: Male and Female Gonadal Problems (Endocrine
Disorders) Market Sales Breakdown by Region/Country in
Percentage: 2012 VS 2020 VS 2027

Table 52: Heart Disorders (Endocrine Disorders) Geographic
Market Spread Worldwide in US$ Million: 2020 to 2027

Table 53: Heart Disorders (Endocrine Disorders) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2012 to
2019

Table 54: Heart Disorders (Endocrine Disorders) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 55: Hypertensive Disorders (Endocrine Disorders) World
Market Estimates and Forecasts by Region/Country in US$
Million: 2020 to 2027

Table 56: Hypertensive Disorders (Endocrine Disorders) Market
Historic Review by Region/Country in US$ Million: 2012 to 2019

Table 57: Hypertensive Disorders (Endocrine Disorders) Market
Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 58: Thyroid Disorders (Endocrine Disorders) World Market
by Region/Country in US$ Million: 2020 to 2027

Table 59: Thyroid Disorders (Endocrine Disorders) Historic
Market Analysis by Region/Country in US$ Million: 2012 to 2019

Table 60: Thyroid Disorders (Endocrine Disorders) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 61: Pituitary Disorders (Endocrine Disorders) World
Market Estimates and Forecasts in US$ Million by
Region/Country: 2020 to 2027

Table 62: Pituitary Disorders (Endocrine Disorders) Market
Worldwide Historic Review by Region/Country in US$ Million:
2012 to 2019

Table 63: Pituitary Disorders (Endocrine Disorders) Market
Percentage Share Distribution by Region/Country: 2012 VS 2020
VS 2027

Table 64: Immunoassay Technology (Testing Technology) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2020 to 2027

Table 65: Immunoassay Technology (Testing Technology) Global
Historic Demand in US$ Million by Region/Country: 2012 to 2019

Table 66: Immunoassay Technology (Testing Technology) Market
Share Distribution in Percentage by Region/Country: 2012 VS
2020 VS 2027

Table 67: Tandem Mass Spectrometry (Testing Technology) World
Market by Region/Country in US$ Million: 2020 to 2027

Table 68: Tandem Mass Spectrometry (Testing Technology)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019

Table 69: Tandem Mass Spectrometry (Testing Technology) Market
Share Breakdown of Worldwide Sales by Region/Country: 2012 VS
2020 VS 2027

Table 70: Sensors Technology (Testing Technology) Potential
Growth Markets Worldwide in US$ Million: 2020 to 2027

Table 71: Sensors Technology (Testing Technology) Historic
Market Perspective by Region/Country in US$ Million: 2012 to
2019

Table 72: Sensors Technology (Testing Technology) Market Sales
Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 73: Monoclonal and Polyclonal Antibody Technology
(Testing Technology) Geographic Market Spread Worldwide in US$
Million: 2020 to 2027

Table 74: Monoclonal and Polyclonal Antibody Technology
(Testing Technology) Region Wise Breakdown of Global Historic
Demand in US$ Million: 2012 to 2019

Table 75: Monoclonal and Polyclonal Antibody Technology
(Testing Technology) Market Share Distribution in Percentage by
Region/Country: 2012 VS 2020 VS 2027

Table 76: Clinical Chemistry Technology (Testing Technology)
World Market Estimates and Forecasts by Region/Country in US$
Million: 2020 to 2027

Table 77: Clinical Chemistry Technology (Testing Technology)
Market Historic Review by Region/Country in US$ Million: 2012
to 2019

Table 78: Clinical Chemistry Technology (Testing Technology)
Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 79: Other Testing Technologies (Testing Technology) World
Market by Region/Country in US$ Million: 2020 to 2027

Table 80: Other Testing Technologies (Testing Technology)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019

Table 81: Other Testing Technologies (Testing Technology)
Market Share Distribution in Percentage by Region/Country: 2012
VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Endocrine Testing Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 82: United States Endocrine Testing Market Estimates and
Projections in US$ Million by Test Type: 2020 to 2027

Table 83: Endocrine Testing Market in the United States by Test
Type: A Historic Review in US$ Million for 2012-2019

Table 84: United States Endocrine Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 85: United States Endocrine Testing Market Estimates and
Projections in US$ Million by Endocrine Disorders: 2020 to 2027

Table 86: Endocrine Testing Market in the United States by
Endocrine Disorders: A Historic Review in US$ Million for
2012-2019

Table 87: United States Endocrine Testing Market Share
Breakdown by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 88: United States Endocrine Testing Market Estimates and
Projections in US$ Million by Testing Technology: 2020 to 2027

Table 89: Endocrine Testing Market in the United States by
Testing Technology: A Historic Review in US$ Million for
2012-2019

Table 90: United States Endocrine Testing Market Share
Breakdown by Testing Technology: 2012 VS 2020 VS 2027

CANADA
Table 91: Canadian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 92: Canadian Endocrine Testing Historic Market Review by
Test Type in US$ Million: 2012-2019

Table 93: Endocrine Testing Market in Canada: Percentage Share
Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 94: Canadian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Endocrine Disorders: 2020 to 2027

Table 95: Canadian Endocrine Testing Historic Market Review by
Endocrine Disorders in US$ Million: 2012-2019

Table 96: Endocrine Testing Market in Canada: Percentage Share
Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
2027

Table 97: Canadian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Testing Technology: 2020 to 2027

Table 98: Canadian Endocrine Testing Historic Market Review by
Testing Technology in US$ Million: 2012-2019

Table 99: Endocrine Testing Market in Canada: Percentage Share
Breakdown of Sales by Testing Technology for 2012, 2020, and
2027

JAPAN
Table 100: Japanese Market for Endocrine Testing: Annual Sales
Estimates and Projections in US$ Million by Test Type for the
Period 2020-2027

Table 101: Endocrine Testing Market in Japan: Historic Sales
Analysis in US$ Million by Test Type for the Period 2012-2019

Table 102: Japanese Endocrine Testing Market Share Analysis by
Test Type: 2012 VS 2020 VS 2027

Table 103: Japanese Market for Endocrine Testing: Annual Sales
Estimates and Projections in US$ Million by Endocrine Disorders
for the Period 2020-2027

Table 104: Endocrine Testing Market in Japan: Historic Sales
Analysis in US$ Million by Endocrine Disorders for the Period
2012-2019

Table 105: Japanese Endocrine Testing Market Share Analysis by
Endocrine Disorders: 2012 VS 2020 VS 2027

Table 106: Japanese Market for Endocrine Testing: Annual Sales
Estimates and Projections in US$ Million by Testing Technology
for the Period 2020-2027

Table 107: Endocrine Testing Market in Japan: Historic Sales
Analysis in US$ Million by Testing Technology for the Period
2012-2019

Table 108: Japanese Endocrine Testing Market Share Analysis by
Testing Technology: 2012 VS 2020 VS 2027

CHINA
Table 109: Chinese Endocrine Testing Market Growth Prospects in
US$ Million by Test Type for the Period 2020-2027

Table 110: Endocrine Testing Historic Market Analysis in China
in US$ Million by Test Type: 2012-2019

Table 111: Chinese Endocrine Testing Market by Test Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 112: Chinese Endocrine Testing Market Growth Prospects in
US$ Million by Endocrine Disorders for the Period 2020-2027

Table 113: Endocrine Testing Historic Market Analysis in China
in US$ Million by Endocrine Disorders: 2012-2019

Table 114: Chinese Endocrine Testing Market by Endocrine
Disorders: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 115: Chinese Endocrine Testing Market Growth Prospects in
US$ Million by Testing Technology for the Period 2020-2027

Table 116: Endocrine Testing Historic Market Analysis in China
in US$ Million by Testing Technology: 2012-2019

Table 117: Chinese Endocrine Testing Market by Testing
Technology: Percentage Breakdown of Sales for 2012, 2020, and
2027

EUROPE
Market Facts & Figures
European Endocrine Testing Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 118: European Endocrine Testing Market Demand Scenario in
US$ Million by Region/Country: 2020-2027

Table 119: Endocrine Testing Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 120: European Endocrine Testing Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 121: European Endocrine Testing Market Estimates and
Forecasts in US$ Million by Test Type: 2020-2027

Table 122: Endocrine Testing Market in Europe in US$ Million by
Test Type: A Historic Review for the Period 2012-2019

Table 123: European Endocrine Testing Market Share Breakdown by
Test Type: 2012 VS 2020 VS 2027

Table 124: European Endocrine Testing Market Estimates and
Forecasts in US$ Million by Endocrine Disorders: 2020-2027

Table 125: Endocrine Testing Market in Europe in US$ Million by
Endocrine Disorders: A Historic Review for the Period
2012-2019

Table 126: European Endocrine Testing Market Share Breakdown by
Endocrine Disorders: 2012 VS 2020 VS 2027

Table 127: European Endocrine Testing Market Estimates and
Forecasts in US$ Million by Testing Technology: 2020-2027

Table 128: Endocrine Testing Market in Europe in US$ Million by
Testing Technology: A Historic Review for the Period 2012-2019

Table 129: European Endocrine Testing Market Share Breakdown by
Testing Technology: 2012 VS 2020 VS 2027

FRANCE
Table 130: Endocrine Testing Market in France by Test Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 131: French Endocrine Testing Historic Market Scenario in
US$ Million by Test Type: 2012-2019

Table 132: French Endocrine Testing Market Share Analysis by
Test Type: 2012 VS 2020 VS 2027

Table 133: Endocrine Testing Market in France by Endocrine
Disorders: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 134: French Endocrine Testing Historic Market Scenario in
US$ Million by Endocrine Disorders: 2012-2019

Table 135: French Endocrine Testing Market Share Analysis by
Endocrine Disorders: 2012 VS 2020 VS 2027

Table 136: Endocrine Testing Market in France by Testing
Technology: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 137: French Endocrine Testing Historic Market Scenario in
US$ Million by Testing Technology: 2012-2019

Table 138: French Endocrine Testing Market Share Analysis by
Testing Technology: 2012 VS 2020 VS 2027

GERMANY
Table 139: Endocrine Testing Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Test Type for the
Period 2020-2027

Table 140: German Endocrine Testing Historic Market Analysis in
US$ Million by Test Type: 2012-2019

Table 141: German Endocrine Testing Market Share Breakdown by
Test Type: 2012 VS 2020 VS 2027

Table 142: Endocrine Testing Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Endocrine
Disorders for the Period 2020-2027

Table 143: German Endocrine Testing Historic Market Analysis in
US$ Million by Endocrine Disorders: 2012-2019

Table 144: German Endocrine Testing Market Share Breakdown by
Endocrine Disorders: 2012 VS 2020 VS 2027

Table 145: Endocrine Testing Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Testing
Technology for the Period 2020-2027

Table 146: German Endocrine Testing Historic Market Analysis in
US$ Million by Testing Technology: 2012-2019

Table 147: German Endocrine Testing Market Share Breakdown by
Testing Technology: 2012 VS 2020 VS 2027

ITALY
Table 148: Italian Endocrine Testing Market Growth Prospects in
US$ Million by Test Type for the Period 2020-2027

Table 149: Endocrine Testing Historic Market Analysis in Italy
in US$ Million by Test Type: 2012-2019

Table 150: Italian Endocrine Testing Market by Test Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 151: Italian Endocrine Testing Market Growth Prospects in
US$ Million by Endocrine Disorders for the Period 2020-2027

Table 152: Endocrine Testing Historic Market Analysis in Italy
in US$ Million by Endocrine Disorders: 2012-2019

Table 153: Italian Endocrine Testing Market by Endocrine
Disorders: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 154: Italian Endocrine Testing Market Growth Prospects in
US$ Million by Testing Technology for the Period 2020-2027

Table 155: Endocrine Testing Historic Market Analysis in Italy
in US$ Million by Testing Technology: 2012-2019

Table 156: Italian Endocrine Testing Market by Testing
Technology: Percentage Breakdown of Sales for 2012, 2020, and
2027

UNITED KINGDOM
Table 157: United Kingdom Market for Endocrine Testing: Annual
Sales Estimates and Projections in US$ Million by Test Type for
the Period 2020-2027

Table 158: Endocrine Testing Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Test Type for the
Period 2012-2019

Table 159: United Kingdom Endocrine Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 160: United Kingdom Market for Endocrine Testing: Annual
Sales Estimates and Projections in US$ Million by Endocrine
Disorders for the Period 2020-2027

Table 161: Endocrine Testing Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Endocrine Disorders
for the Period 2012-2019

Table 162: United Kingdom Endocrine Testing Market Share
Analysis by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 163: United Kingdom Market for Endocrine Testing: Annual
Sales Estimates and Projections in US$ Million by Testing
Technology for the Period 2020-2027

Table 164: Endocrine Testing Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Testing Technology
for the Period 2012-2019

Table 165: United Kingdom Endocrine Testing Market Share
Analysis by Testing Technology: 2012 VS 2020 VS 2027

SPAIN
Table 166: Spanish Endocrine Testing Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 167: Spanish Endocrine Testing Historic Market Review by
Test Type in US$ Million: 2012-2019

Table 168: Endocrine Testing Market in Spain: Percentage Share
Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 169: Spanish Endocrine Testing Market Estimates and
Forecasts in US$ Million by Endocrine Disorders: 2020 to 2027

Table 170: Spanish Endocrine Testing Historic Market Review by
Endocrine Disorders in US$ Million: 2012-2019

Table 171: Endocrine Testing Market in Spain: Percentage Share
Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
2027

Table 172: Spanish Endocrine Testing Market Estimates and
Forecasts in US$ Million by Testing Technology: 2020 to 2027

Table 173: Spanish Endocrine Testing Historic Market Review by
Testing Technology in US$ Million: 2012-2019

Table 174: Endocrine Testing Market in Spain: Percentage Share
Breakdown of Sales by Testing Technology for 2012, 2020, and
2027

RUSSIA
Table 175: Russian Endocrine Testing Market Estimates and
Projections in US$ Million by Test Type: 2020 to 2027

Table 176: Endocrine Testing Market in Russia by Test Type:
A Historic Review in US$ Million for 2012-2019

Table 177: Russian Endocrine Testing Market Share Breakdown by
Test Type: 2012 VS 2020 VS 2027

Table 178: Russian Endocrine Testing Market Estimates and
Projections in US$ Million by Endocrine Disorders: 2020 to 2027

Table 179: Endocrine Testing Market in Russia by Endocrine
Disorders: A Historic Review in US$ Million for 2012-2019

Table 180: Russian Endocrine Testing Market Share Breakdown by
Endocrine Disorders: 2012 VS 2020 VS 2027

Table 181: Russian Endocrine Testing Market Estimates and
Projections in US$ Million by Testing Technology: 2020 to 2027

Table 182: Endocrine Testing Market in Russia by Testing
Technology: A Historic Review in US$ Million for 2012-2019

Table 183: Russian Endocrine Testing Market Share Breakdown by
Testing Technology: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 184: Rest of Europe Endocrine Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027

Table 185: Endocrine Testing Market in Rest of Europe in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 186: Rest of Europe Endocrine Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 187: Rest of Europe Endocrine Testing Market Estimates
and Forecasts in US$ Million by Endocrine Disorders: 2020-2027

Table 188: Endocrine Testing Market in Rest of Europe in US$
Million by Endocrine Disorders: A Historic Review for the
Period 2012-2019

Table 189: Rest of Europe Endocrine Testing Market Share
Breakdown by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 190: Rest of Europe Endocrine Testing Market Estimates
and Forecasts in US$ Million by Testing Technology: 2020-2027

Table 191: Endocrine Testing Market in Rest of Europe in US$
Million by Testing Technology: A Historic Review for the Period
2012-2019

Table 192: Rest of Europe Endocrine Testing Market Share
Breakdown by Testing Technology: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 193: Asia-Pacific Endocrine Testing Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 194: Endocrine Testing Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2012-2019

Table 195: Asia-Pacific Endocrine Testing Market Share Analysis
by Region/Country: 2012 VS 2020 VS 2027

Table 196: Endocrine Testing Market in Asia-Pacific by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 197: Asia-Pacific Endocrine Testing Historic Market
Scenario in US$ Million by Test Type: 2012-2019

Table 198: Asia-Pacific Endocrine Testing Market Share Analysis
by Test Type: 2012 VS 2020 VS 2027

Table 199: Endocrine Testing Market in Asia-Pacific by
Endocrine Disorders: Estimates and Projections in US$ Million
for the Period 2020-2027

Table 200: Asia-Pacific Endocrine Testing Historic Market
Scenario in US$ Million by Endocrine Disorders: 2012-2019

Table 201: Asia-Pacific Endocrine Testing Market Share Analysis
by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 202: Endocrine Testing Market in Asia-Pacific by Testing
Technology: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 203: Asia-Pacific Endocrine Testing Historic Market
Scenario in US$ Million by Testing Technology: 2012-2019

Table 204: Asia-Pacific Endocrine Testing Market Share Analysis
by Testing Technology: 2012 VS 2020 VS 2027

AUSTRALIA
Table 205: Endocrine Testing Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Test Type for the
Period 2020-2027

Table 206: Australian Endocrine Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 207: Australian Endocrine Testing Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 208: Endocrine Testing Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Endocrine
Disorders for the Period 2020-2027

Table 209: Australian Endocrine Testing Historic Market
Analysis in US$ Million by Endocrine Disorders: 2012-2019

Table 210: Australian Endocrine Testing Market Share Breakdown
by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 211: Endocrine Testing Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Testing
Technology for the Period 2020-2027

Table 212: Australian Endocrine Testing Historic Market
Analysis in US$ Million by Testing Technology: 2012-2019

Table 213: Australian Endocrine Testing Market Share Breakdown
by Testing Technology: 2012 VS 2020 VS 2027

INDIA
Table 214: Indian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 215: Indian Endocrine Testing Historic Market Review by
Test Type in US$ Million: 2012-2019

Table 216: Endocrine Testing Market in India: Percentage Share
Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 217: Indian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Endocrine Disorders: 2020 to 2027

Table 218: Indian Endocrine Testing Historic Market Review by
Endocrine Disorders in US$ Million: 2012-2019

Table 219: Endocrine Testing Market in India: Percentage Share
Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
2027

Table 220: Indian Endocrine Testing Market Estimates and
Forecasts in US$ Million by Testing Technology: 2020 to 2027

Table 221: Indian Endocrine Testing Historic Market Review by
Testing Technology in US$ Million: 2012-2019

Table 222: Endocrine Testing Market in India: Percentage Share
Breakdown of Sales by Testing Technology for 2012, 2020, and
2027

SOUTH KOREA
Table 223: Endocrine Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027

Table 224: South Korean Endocrine Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 225: Endocrine Testing Market Share Distribution in South
Korea by Test Type: 2012 VS 2020 VS 2027

Table 226: Endocrine Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Endocrine
Disorders for the Period 2020-2027

Table 227: South Korean Endocrine Testing Historic Market
Analysis in US$ Million by Endocrine Disorders: 2012-2019

Table 228: Endocrine Testing Market Share Distribution in South
Korea by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 229: Endocrine Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Testing
Technology for the Period 2020-2027

Table 230: South Korean Endocrine Testing Historic Market
Analysis in US$ Million by Testing Technology: 2012-2019

Table 231: Endocrine Testing Market Share Distribution in South
Korea by Testing Technology: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 232: Rest of Asia-Pacific Market for Endocrine Testing:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027

Table 233: Endocrine Testing Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Test Type for the
Period 2012-2019

Table 234: Rest of Asia-Pacific Endocrine Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 235: Rest of Asia-Pacific Market for Endocrine Testing:
Annual Sales Estimates and Projections in US$ Million by
Endocrine Disorders for the Period 2020-2027

Table 236: Endocrine Testing Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Endocrine Disorders
for the Period 2012-2019

Table 237: Rest of Asia-Pacific Endocrine Testing Market Share
Analysis by Endocrine Disorders: 2012 VS 2020 VS 2027

Table 238: Rest of Asia-Pacific Market for Endocrine Testing:
Annual Sales Estimates and Projections in US$ Million by
Testing Technology for the Period 2020-2027

Table 239: Endocrine Testing Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Testing Technology
for the Period 2012-2019

Table 240: Rest of Asia-Pacific Endocrine Testing Market Share
Analysis by Testing Technology: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 241: Latin American Endocrine Testing Market Trends by
Region/Country in US$ Million: 2020-2027

Table 242: Endocrine Testing Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 243: Latin American Endocrine Testing Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027

Table 244: Latin American Endocrine Testing Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027

Table 245: Endocrine Testing Historic Market Analysis in Latin
America in US$ Million by Test Type: 2012-2019

Table 246: Latin American Endocrine Testing Marketby Test Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 247: Latin American Endocrine Testing Market Growth
Prospects in US$ Million by Endocrine Disorders for the Period
2020-2027

Table 248: Endocrine Testing Historic Market Analysis in Latin
America in US$ Million by Endocrine Disorders: 2012-2019

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05956690/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001